Walleye Capital LLC Bio Rad Laboratories, Inc. Transaction History

Walleye Capital LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$268.26 - $339.48 $402,390 - $509,220	1,500 New	1,500 $409,000
Q4 2023 Feb 14, 2024	BUY	$269.37 - $365.04 $345,062 - $467,616	1,281 New	1,281 $413,000
Q4 2022 Feb 14, 2023	SELL	$351.71 - $456.01 $2.66 Million - $3.45 Million	-7,564 Reduced 69.43%	3,330 $1.4 Million
Q3 2022 Nov 14, 2022	BUY	$412.59 - $563.26 $3.4 Million - $4.64 Million	8,233 Added 309.39%	10,894 $4.54 Million
Q2 2022 Aug 08, 2022	SELL	$463.67 - $597.16 $2.77 Million - $3.57 Million	-5,983 Reduced 69.22%	2,661 $1.32 Million
Q1 2022 May 16, 2022	BUY	$524.57 - $735.42 $3.99 Million - $5.59 Million	7,600 Added 727.97%	8,644 $4.87 Million
Q4 2021 Mar 03, 2022	BUY	$708.84 - $794.68 $198,475 - $222,510	280 Added 36.65%	1,044 $788,000
Q3 2021 Nov 15, 2021	BUY	$657.71 - $825.77 $495,913 - $622,630	754 Added 7540.0%	764 $570,000
Q3 2019 Nov 14, 2019	SELL	$304.55 - $345.24 $6,091 - $6,904	-20 Reduced 66.67%	10 $3,000
Q2 2019 Aug 14, 2019	BUY	$286.93 - $312.59 $8,607 - $9,377	30 New	30 $9,000

457

18.3M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $7.89B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.